Juan M. Hincapie-Castillo/LinkedIn
Feb 28, 2026, 03:58
Juan M. Hincapie-Castillo: FDA Releases Draft 2026 Guidance Plans Including Endometriosis-Associated Pain
Juan M. Hincapie-Castillo, Associate Professor at University of Pittsburgh, shared a post on LinkedIn:
“The FDA Center for Drug Evaluation and Research released its New and Revised Draft Guidances Planned for Publication in CY 2026.
A few that stand out to me working in RWE, drug safety, and pain:
- Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
- Considerations for the Inclusion of Older Adults in Clinical Trials
- Endometriosis-Associated Pain: Establishing Effectiveness and Safety of Drugs for Management
- Sickle Cell Disease: Endpoints for the Development of Products for Prevention and Treatment of SCD Complications
- Development of a Shared System or Separate REMS.”
Proceed to the pages attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 9, 2026, 18:30Christopher Robinson: The Nausicaä Suture in the Management of the Placenta Accreta Spectrum
-
Jun 9, 2026, 18:28Ronald Feinberg: Bridging the Gap Between Fertility and Menopause Care
-
Jun 9, 2026, 18:26Hala El Damanhoury: The Right Questions Shape Better Birth Experiences
-
Jun 9, 2026, 18:25Call for Reviewers, AI in Gynecologic Cancer Literature – IJGC
-
Jun 9, 2026, 18:21Julie Morgan: How Generative AI Is Reshaping Fertility Care?
-
Jun 9, 2026, 18:19Simone Ferrero: The Diagnosis of Endometriosis, From Vision to Publication
-
Jun 9, 2026, 18:17Scammers Are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers! – ESHRE
-
Jun 9, 2026, 18:15Diagnostic Challenge, Looking Beyond Renal Duplication and Ureterocele! – CFEF
-
Jun 9, 2026, 18:13Christopher Robinson: Trends in Antenatal Corticosteroid Use in Late Preterm Multiple Gestations